28.06
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
27.24%
1.999
|
1.571 | 2.17 | 7.57 | 9.018 |
|
|
10.83%
341.15
|
307.80 | 287.09 | 292.54 | 283.40 |
| Benefits Costs and Expenses |
82.03%
292.37
|
160.62 | 271.43 | 210.62 | 243.53 |
| Costs And Expenses |
82.03%
292.37
|
160.62 | 271.43 | 210.62 | 243.53 |
| Operating Income/Loss |
10.75%
-339.15
|
-306.23 | -284.92 | -284.96 | -274.38 |
| Income/Loss From Continuing Operations Before Tax |
82.57%
-290.37
|
-159.04 | -269.26 | -203.05 | -234.51 |
| Income Tax Expense/Benefit |
233.55%
23.33
|
6.995 | 4.649 | 49.32 | -25.57 |
| Income/Loss From Continuing Operations After Tax |
88.93%
-313.70
|
-166.04 | -273.91 | -252.38 | -208.94 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | - | 327.02 |
|
|
88.93%
-313.70
|
-166.04 | -273.91 | -252.38 | 118.08 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
8.97%
-47.81
|
-52.52 | -50.56 | -45.90 | -51.31 |
| Basic Average Shares |
2.34%
696.86
|
680.95 | 680.29 | -5.9226 | 722.72 |
| Diluted Average Shares |
2.34%
696.86
|
680.95 | 680.29 | -5.9226 | 722.72 |
| Basic Earnings Per Share |
123.53%
-0.38
|
-0.17 | -0.33 | -0.29 | 0.23 |
| Diluted Earnings Per Share |
123.53%
-0.38
|
-0.17 | -0.33 | -0.29 | 0.23 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):